A designed dual‐acting melatonin–sulforaphane hybrid

E-ISSN： 1476-5381|172|7|1807-1821

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.7, 2015-04, pp. : 1807-1821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depression

By Rickels Karl Athanasiou Maria Reed Carol

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 217-224

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1004-1011

John Wiley & Sons Inc

Access to resources Recommend Favorite

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 840-841

John Wiley & Sons Inc

Access to resources Recommend Favorite

ANTIOXIDATIVE EFFECT OF MELATONIN ON HUMAN SPERMATOZOA

By Gavella Mirjana Lipovac Vaskresenija

Archives of Andrology, Vol. 44, Iss. 1, 2000-01 ,pp. : 23-27

Informa Healthcare

Access to resources Recommend Favorite